Ocrevus as a first-line treatment for early relapsing MS is better at delaying disease progression than starting with a less ...

Relapsing-remitting multiple sclerosis is a type of multiple sclerosis in which you experience relapses of the disease with periods of remission occurring in between. Relapsing-remitting multiple ...

A registry study led by the University of Oulu examined the early-stage treatment of relapsing-remitting multiple sclerosis ...

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

I'm Dr. John Whyte, the Chief Medical Officer at WebMD. Today, I want to talk a little bit about relapsing multiple sclerosis, particularly about the loss of cognitive function in patients.

There are relapsing-remitting and progressive types of MS, but the course is rarely predictable. Researchers still don’t fully understand the cause of MS or why the rate of progression is so ...

A Phase 2 clinical trial testing obexelimab in adults with relapsing types of multiple sclerosis is now recruiting ...

Most people with multiple sclerosis (MS) have a type called relapsing-remitting MS (RRMS). It usually starts in your 20s or 30s. One study shows that people who began treatment when their first ...

Kesimpta was approved in August 2020 as an injection for subcutaneous use for the treatment of relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing ...